Restricted accessResearch articleFirst published online 1983-10
A Long Term Prospective Study of Electroencephalographic and Neuropsychological Correlates of Tardive Dyskinesia: Initial Findings at Five Year Follow-Up
SchöneckerM., Ein eigentumliches syndrom in oralen Bereich: Megaphen-applikation, Nervanarzt, 28:35–36, 1957.
2.
SigwaldJ.BouttierD.RaymondC., Quatre cas de dyskinesie facia-buccolinquo -masticatrice a evolution prolongie secondaire a un traitment par les neuroleptiques, Rev. Neurol. (Paris), 100:751–755, 1959.
3.
CraneG.E., Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature, Amer. J. Psychiat., 124:40–48, 1968.
4.
PaulsonG.W., An evaluation of the permanence of the “tardive dyskinesias,”Dis. Nerv. Syst., 24:692–694, 1968.
5.
SchieleB.C.GallantD.SimpsonG., Neurological syndromes associated with antipsychotic drug use, Arch. Gen. Psychiat., 28:463–466, 1973.
6.
BaldessariniR.J., and LipinskiJ.F., Risks vs. benefits of antipsychotic drugs, N. Eng. J. Med., 290:427–428, 1973.
7.
CraneG.E., Persistent dyskinesia, Brit. J. Psychiat., 122:395–405, 1973.
8.
TarsyD., and BaldessariniR.J., The tardive dyskinesia syndrome. In KlawansH.L. (Ed.) Clinical Neuropharmacology, New York, Raven Press, 1976.
9.
KobayashiR.M., Orofacial dyskinesia: Clinical features, mechanisms, and drug therapy, West. J. Med., 125:277–288, 1976.
10.
CraneG.E., and SmithR.C., The prevalence of tardive dyskinesia. In FannW.E.SmithR.C.DavisJ.M., and DominoE.F. (Eds.) Tardive Dyskinesia: Research and Treatment, New York, Spectrum Publications, 1980.
11.
FannW.E., Tardive dyskinesia and other drug-induced movement disorders. In FannW.E.SmithR.C.DavisJ.M., and DominoG.F. (eds.) Tardive Dyskinesia: Research and Treatment, New York, Spectrum Publications, 1980.
12.
JesteD.J., and WyattR.J., Understanding and Treating Tardive Dyskinesia, New York, The Guilford Press, 1982.
13.
GardosG.ColeJ.O., and LabrieR.A., Drug variables in the etiology of tardive dyskinesia: Application of discriminant function analysis, Progress in Neuropsychopharmacology, 1:147–154, 1977.
14.
SimpsonG.M.VargaE.LeeJ.H., Tardive dyskinesia and psychotropic drug history, Psychopharmacology, 58:117–124, 1978.
15.
JesteD.V.PotkinS.G.SinhaS., Tardive dyskinesia - reversible and persistent. Arch Gen. Psychiat.36:585–590, 1979.
16.
SyvälahtiE.LehtinenI., and SalokangasR., Neuroleptic treatment and tardive dyskinesia - Clinical, neurophysiological and neuroendocrinological studies in schizophrenic patients. Third World Congress of Biological Psychiatry, Stockholm, Sweden, June 28 - July 3, 1981.
17.
EdwardsH., The significance of brain damage in persistent oral dyskinesia, Brit. J. Psychiat., 116:271–275, 1970.
18.
WaltonD.WhiteJ.G., and BlackD.A., A modified word-learning test: A cross-validation study, Brit. J. Med. Psychol., 32:213–220, 1970.
19.
PryceI.G., and EdwardsH., Persistent oral dyskinesia in female mental hospital patients, Brit. J. Psychiat., 112:983–987, 1966.
20.
AsnisG.M.LeopoldM.A.DuvoisinR.C., A survey of tardive dyskinesia in psychiatric outpatients, Am. J. Psychiat., 134:1367–1370, 1977.
21.
FamuyiwaO.O.EcclestonD.DonaldsonA.A., Tardive dyskinesia and dementia, Brit., J. Psychiat., 135:500–504, 1979.
22.
JoseC.MallyaA.MethaD., Iatrogenic morbidity in patients taking depot fluphenazine, Am. J. Psychiat., 136:976–977, 1979.
23.
KaneJ.M.WoernerM.WeinholdP., Results from a prospective study of tardive dyskinesia development: Preliminary findings over a 2-year period, Psychopharm. Bull., 18:82–83, 1982.
24.
KaneJ.M.WoernerM.WeinholdP., A prospective study of risk factors in the development of tardive dyskinesia, Foundations Fund for Research and Psychiatry meeting on the Prevention and Treatment of Tardive Dyskinesia, San Diego, California, December 18–19, 1981.
25.
StruveF.A.WegnerJ.T.KaneJ.M., and QuitkinF., The mitten pattern as a potential EEG predictor of tardive dyskinesia. American Medical Electroencephalographic Association Meetings, Montreal, Canada, June 3–4, 1977.
26.
StruveF.A.KaneJ.M.WegnerJ.T., and KantorJ., Relationship of mitten patterns to neuroleptic drug induced dyskinesias in psychiatric patients: Early investigative findings, Clin. Electroenceph., 10:151–163, 1979.
27.
SimpsonG.M.LeeJ.H.ZoubakB., A rating scale for tardive dyskinesia, Psychopharmacology, 64:171–179, 1979.
28.
SimpsonG.M., and AngusJ.W., A rating scale for extra-pyramidal side effects, Acta Psychiat. Scand. (suppl), 212:11–19, 1970.
29.
OverallJ.E., and GorhamD.R., The Brief Psychiatric Rating Scale, Psychol. Rep., 10:799–812, 1962.
30.
WillnerA.E., Conceptual Level Analogy Test, New York, Cognitive Testing Service, 1971.
31.
ReitanR.M., Validity of the Trail Making test as an indicator of organic brain damage, Percept. Mot. Skills, 8:271–276, 1958.
32.
StruveF.A., and BeckaD.R., The relative incidence of the B-Mitten EEG pattern in process and reactive schizophrenia, Electroenceph. Clin. Neurophysiol., 24:80–82, 1968.
33.
StruveF.A.BeckaD.R., and KleinD.F., The relationship of the B-Mitten EEG pattern to process and reactive schizophrenia: A replication, Arch Gen. Psychiat., 26:189–192, 1972.
34.
StruveF.A.BeckaD.R.GreenM.A., and HowardA., Reliability of clinical electroencephalographic interpretation, Clin. Electroenceph., 6:54–60, 1975.
35.
StruveF.A.RamseyP.P., and WillnerA.E., Neuropsychological and electroencephalographic correlates of neuroleptic induced involuntary movements: Implications for tardive dyskinesia, In MalateshaR.N., and HartlageL.C. (Eds.) Neuropsychology and Cognition Volume II, The Hague, Martinus Nijhoff Publishers, 1982.
36.
WillnerA.E.RabinerC.J.WisoffB.G., Analogy tests and psychopathology after open heart surgery, Biol. Psychiat., 11:687–696, 1976.
37.
WillnerA.E.RabinerC.J.WisoffB.G., Analogical reasoning and postoperative outcome in patients scheduled for open heart surgery, Arch. Gen. Psychiat., 33:255–259, 1976.
38.
WillnerA.E., and RabinerC.J., Psychopathology and cognitive dysfunction five years after open heart surgery, Comprehensive Psychiat., 20:409–418, 1979.
39.
ElseB., and HastingsJ., Personal Communications (To A.E. Willner), 1979, 1980.
40.
SchoolerN., and KaneJ.M., Research diagnoses for tardive dyskinesia, Arch. Gen. Psychiat., 38:486, 1982.
41.
CochranW.G., Some methods for strengthening the common X2 tests, Biometrics, 10:417–451, 1954.
42.
HalaszP., and NagyT.A., The mitten pattern: An abnormality in sleep, Acta Medica. Hungary, 21:311–318, 1965.
43.
StruveF.A.BurnettL., and BeckaD.R., Chronological age distribution of the B-Mitten EEG pattern, Clin. Electroenceph., 4:135–139, 1973.
44.
WegnerJ.T.StruveF.A.KantorJ.S., Relationship between the B-Mitten EEG pattern and tardive dyskinesia: A pilot control study, Arch. Gen. Psychiat., 36:599–603, 1979.
45.
LeemhuisA.J., and StampsF., Mitten patterns in electroencephalograms of patients with Parkinsonism. Read at American EEG Society Meetings, Atlantic City, June, 1949.
46.
WinfieldD.L., and SparerP.J., The electroencephalogram in paralysis agitans, Dis. Nerv. Syst., 15:114–117, 1954.
47.
GibbsF.A., and GibbsE.L., Tumor sites in cases of brain tumor with mitten patterns in the electroencephalogram, Clin. electroenceph., 4:206–208, 1973.
48.
DavisK.L.Berger, and HollisterL.E., Tardive dyskinesia and depressive illness, Psychopharm. Communications2:125–130, 1976.
49.
RosenbaumK.H.NivenR.G.HansonN.P., Tardive dyskinesia: Relationship with a primary affective disorder. Dis. Nerv. Syst.38:423–427, 1977.
50.
HamraB.J.NasrallahH.A.ClancyJ., Psychiatric diagnosis and risk for tardive dyskinesia, Arch. Gen. Psychiat., 40:346–347, 1983.
51.
StruveF.A.BeckaD.R., and KleinD.F., The B-Mitten EEG pattern in process and reactive schizophrenia and affective states, Clin. Electroenceph., 3:136–144, 1972.
52.
StruveF.A., and KleinD.F., Diagnostic implications of the B-Mitten pattern: Relationship to primary and secondary affective dysregulation, Biol. Psychiat., 11:599–611, 1976.
53.
ÖbergR., and DuvacI., “Cognitive” functions of the Neostriatum. In DivacI. and ObergR. (Eds) The Neostriatum, New York, Pegamon Press, 1979.